Two homegrown Covid-19 Vaccines Receives the Go-Ahead
The Indovac Covid-19 vaccine was developed by state-owned pharmaceutical firm PT Bio Farma, while the AWcorna Covid-19 vaccine was developed by PT Etana Biotechnologies Indonesia.
/https%3A%2F%2Fasset.kgnewsroom.com%2Fphoto%2Fpre%2F2022%2F01%2F25%2F152eb71e-e22e-4615-af39-d16b70272c92_jpg.jpg){kind=logo}
Medical personnel inject the third dose of Covid-19 vaccine (booster) to workers at the Kompas Tower, Jakarta, on Tuesday (25/1/2022).
JAKARTA, KOMPAS - The Food and Drug Monitoring Agency (BPOM) issued emergency use authorizations (EUA) for two locally developed Covid-19 vaccines, namely the Indovac vaccine and the AWcorna vaccine. The granting of the EUAs also reflects Indonesia’s increasing independence in vaccine production.
The Indovac Covid-19 vaccine was developed by state-owned pharmaceutical firm PT Bio Farma, while the AWcorna Covid-19 vaccine was developed by PT Etana Biotechnologies Indonesia. The EUAs guarantee both vaccines’ efficacy and safety.